W
BIIB icon

WealthCollab’s Biogen BIIB Stock Holding History

WealthCollab’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.8K Hold
206
– – 0.02% 251
2025
Q4 		$36.3K Hold
206
– – 0.01% 267
2025
Q3 		$28.9K Buy
206
+35
+20% +$4.73K 0.01% 289
2025
Q2 		$21.5K Buy
171
+8
+5% +$997 0.01% 321
2025
Q1 		$22.3K Buy
163
+68
+72% +$9.72K 0.01% 293
2024
Q4 		$14.5K Buy
95
+73
+332% +$12.3K 0.01% 383
2024
Q3 		$4.26K Hold
22
– – ﹤0.01% 645
2024
Q2 		$5.1K Sell
22
-7
-24% -$1.52K ﹤0.01% 581
2024
Q1 		$6.25K Sell
29
-7
-19% -$1.64K ﹤0.01% 534
2023
Q4 		$9.32K Buy
+36
New +$8.84K 0.01% 435

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WealthCollab's BIIB Position: Q1 2026 in Review

WealthCollab held its Biogen (BIIB) position steady in Q1 2026 at 206 shares worth $37.8K. The position accounts for 0.02% of the portfolio, ranked #251.

WealthCollab first reported a position in BIIB in Q4 2023 and has held it in 10 quarters since. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • WealthCollab held 206 shares of Biogen worth $37.8K as of Q1 2026.
  • WealthCollab left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.02% of WealthCollab's portfolio in Q1 2026, its #251 holding.
  • WealthCollab first reported a position in Biogen in Q4 2023 and has held it in 10 quarters since.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.